Get the latest Science News and Discoveries

PolyU collaborates with Axis Therapeutics to establish joint laboratory for immunotherapy - EurekAlert


The Hong Kong Polytechnic University (PolyU) has entered into a formal collaboration with Axis Therapeutics (Axis) to foster cancer immunotherapy research and development, with the aim of improving cancer treatment for patients in Hong Kong. This collaboration will facilitate clinical trials of new T-cell receptor therapy using the newly established clinical Current Good Manufacturing Practice (cGMP) facility at PolyU, which is compliant with the GMP Guide for the Advanced Therapy Products (ATPs), and the development of at least 30 new targeting agents against novel T-cell targets in cancer immunotherapy.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of PolyU

PolyU

Photo of joint laboratory

joint laboratory

Photo of Axis Therapeutics

Axis Therapeutics

Related news:

News photo

Freeze casting - a guide to creating hierarchically structured materials - EurekAlert

News photo

Argonne plays critical role in consortium to advance fuel cell and electrolyzer manufacturing - EurekAlert

News photo

Underwater robot pioneers new energy-efficient buoyancy control - EurekAlert